What does EYESIST do?

EYESIST is a shop in Liège. Public Limited, started on 19 November 1997, 1 establishment.

What is the address of EYESIST?

The registered office of EYESIST is located at Quai de la Boverie 13, 4020 Liège.

Is EYESIST still active?

Yes. According to the CBE (31 October 2026) EYESIST is active, legal situation “Normale toestand”, started on 19 November 1997.

Is EYESIST registered on Peppol?

Yes, EYESIST is registered on the Peppol network with ID 0208:0461933202.

What is the enterprise number of EYESIST?

The enterprise number of EYESIST is BE0461933202.

When was EYESIST founded?

EYESIST was founded on 19 November 1997.

Who are the directors of EYESIST?

According to the 2025 annual accounts, the directors of EYESIST are: Sandrine CREMER, Anne BALON, Géraldine SOHET.

Is EYESIST a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 November 1997; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did EYESIST make in 2025?

EYESIST posted a profit after taxes of € 47,215 in financial year 2025.

What is the revenue of EYESIST?

As a small company, EYESIST is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 98,885.

EYESIST (Public Limited) - Liège - BE0461933202

Dossier EYESIST, printed on 1 November 2026 from databakkes.be/en/0461933202/eyesist. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

EYESIST from Liège, company number BE0461933202, closed financial year 2025 with a result of € 47,215 after tax. For that financial year EYESIST recorded a gross margin of € 98,885 and equity of € 340,534. Compared with financial year 2024, the result moved from € 32,436 to € 47,215. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 1, 2026.

What it is worth Healthy

€ 340,534

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 47,215

▲ 46% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 293,042

▲ 77% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 23,144

▼ 26% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 12,562

▲ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 16,511

▼ 47% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 125,280 Gross margin 2022: € 125,280 First fiscal year in the series	€ 168,525 Gross margin 2023: € 168,525 ▲ 35% vs 2022 (€ 125,280) Favourable step	€ 111,983 Gross margin 2024: € 111,983 ▼ 34% vs 2023 (€ 168,525) Unfavourable step	€ 98,885 Gross margin 2025: € 98,885 ▼ 12% vs 2024 (€ 111,983) Unfavourable step	▼ 12%
Profit after taxes	€ 37,745 Profit after taxes 2022: € 37,745 First fiscal year in the series	€ 77,671 Profit after taxes 2023: € 77,671 ▲ 106% vs 2022 (€ 37,745) Favourable step	€ 32,436 Profit after taxes 2024: € 32,436 ▼ 58% vs 2023 (€ 77,671) Unfavourable step	€ 47,215 Profit after taxes 2025: € 47,215 ▲ 46% vs 2024 (€ 32,436) Favourable step	▲ 46%
Equity	€ 335,212 Equity 2022: € 335,212 First fiscal year in the series	€ 362,882 Equity 2023: € 362,882 ▲ 8% vs 2022 (€ 335,212) Favourable step	€ 343,318 Equity 2024: € 343,318 ▼ 5% vs 2023 (€ 362,882) Unfavourable step	€ 340,534 Equity 2025: € 340,534 ▼ 1% vs 2024 (€ 343,318) Unfavourable step	▼ 1%
Total debts	€ 150,873 Total debts 2022: € 150,873 First fiscal year in the series	€ 117,694 Total debts 2023: € 117,694 ▼ 22% vs 2022 (€ 150,873) Favourable step	€ 125,102 Total debts 2024: € 125,102 ▲ 6% vs 2023 (€ 117,694) Unfavourable step	€ 79,816 Total debts 2025: € 79,816 ▼ 36% vs 2024 (€ 125,102) Favourable step	▼ 36%
Cash	€ 105,352 Cash 2022: € 105,352 First fiscal year in the series	€ 143,992 Cash 2023: € 143,992 ▲ 37% vs 2022 (€ 105,352) Favourable step	€ 165,766 Cash 2024: € 165,766 ▲ 15% vs 2023 (€ 143,992) Favourable step	€ 293,042 Cash 2025: € 293,042 ▲ 77% vs 2024 (€ 165,766) Favourable step	▲ 77%
Retained profit	€ 273,238 Retained profit 2022: € 273,238 First fiscal year in the series	€ 300,909 Retained profit 2023: € 300,909 ▲ 10% vs 2022 (€ 273,238) Favourable step	€ 281,345 Retained profit 2024: € 281,345 ▼ 7% vs 2023 (€ 300,909) Unfavourable step	€ 278,560 Retained profit 2025: € 278,560 ▼ 1% vs 2024 (€ 281,345) Unfavourable step	▼ 1%
Dividend	€ 20,000 Dividend 2022: € 20,000 First fiscal year in the series	€ 50,000 Dividend 2023: € 50,000 ▲ 150% vs 2022 (€ 20,000) Unchanged	€ 52,000 Dividend 2024: € 52,000 ▲ 4% vs 2023 (€ 50,000) Unchanged	€ 50,000 Dividend 2025: € 50,000 ▼ 4% vs 2024 (€ 52,000) Unchanged	▼ 4%
Bank debt	€ 89,197 Bank debt 2022: € 89,197 First fiscal year in the series	€ 12,815 Bank debt 2023: € 12,815 ▼ 86% vs 2022 (€ 89,197) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 12,815) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 486,085 Balance sheet total 2022: € 486,085 First fiscal year in the series	€ 480,577 Balance sheet total 2023: € 480,577 ▼ 1% vs 2022 (€ 486,085) Unchanged	€ 468,420 Balance sheet total 2024: € 468,420 ▼ 3% vs 2023 (€ 480,577) Unchanged	€ 420,350 Balance sheet total 2025: € 420,350 ▼ 10% vs 2024 (€ 468,420) Unchanged	▼ 10%

Key figures of EYESIST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to EYESIST?

What happened at EYESIST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Géraldine SOHET stepped down as director. NBB
2028 Sandrine CREMER stepped down as director. NBB
2028 Anne BALON stepped down as director. NBB
May 1, 2026 New annual accounts for financial year 2025: profit of € 47,215 (▲ 46% vs 2024). Source: NBB ↗
2023 Géraldine SOHET became a director. NBB
2022 Sandrine CREMER became a director. NBB
2022 Anne BALON became a director. NBB
Mar 11, 1998 New establishment in Liège. KBO

In short

From € 37,745 profit in 2022 to € 47,215 profit in 2025.

Paid € 57,163 in corporate taxes since 2022.

Best year ever: 2023, with € 77,671 profit.

Paid out € 172,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

KERATOR 92%

The stake of KERATOR comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

EYESIST

The shares are held by KERATOR (92%).

Directors

According to the 2025 annual accounts

Sandrine CREMER

Director

since 2022 · until 2028

Anne BALON

Managing director

Also active at: TRANSMETAL, IRIS, Chirurgie Oculaire Docteurs PRIJOT et LEROY, KERATOR

since 2022 · until 2028

Géraldine SOHET

Director

since 2023 · until 2029

Shareholders

KERATOR

92%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Quai de la Boverie 13

4020 Liège

2.085.844.547

Avenue Albert-Mahiels 7

4020 Liège

Active since 11 March 1998

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0461.933.202

VAT number

BE 0461.933.202

Registered office

Quai de la Boverie 13, 4020 Liège

Names & denominations

EYESIST

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

19 November 1997

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

EYESIST

Financials

What happened to EYESIST?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions